MannKind Corporation to Participate in SVB Leerink 2022 Global Healthcare ConferenceGlobeNewsWire • 02/10/22
MannKind Corporation to Participate in the Lytham Partners Winter 2021 Investor ConferenceGlobeNewsWire • 12/06/21
MannKind Corporation (MNKD) CEO Michael Castagna on Q3 2021 Results - Earnings Call TranscriptSeeking Alpha • 11/10/21
Mannkind Corporation Closes Sale-Leaseback Transaction Generating $102.25 Million in Non-Dilutive Gross ProceedsGlobeNewsWire • 11/09/21
MannKind Corporation to Hold 2021 Third Quarter Financial Results Conference Call on November 9, 2021GlobeNewsWire • 11/02/21
Will MannKind (MNKD) Report Negative Q3 Earnings? What You Should KnowZacks Investment Research • 10/27/21
MannKind's stock falls 18% after FDA says it will not approve application for hypertension drugMarket Watch • 10/18/21
FDA Declines MannKind - United Therapeutics' Formulated Treprostinil For Lung DiseaseBenzinga • 10/18/21
MannKind Corporation (MNKD) CEO Mike Castagna Presents at Lytham Partners Fall Conference (Transcript)Seeking Alpha • 10/05/21
Do Options Traders Know Something About MannKind (MNKD) Stock We Don't?Zacks Investment Research • 10/04/21
MannKind Announces First Patient Enrolled In Inhale-1 Study Of Afrezza® In Pediatric PopulationPRNewsWire • 10/04/21
Mannkind Corporation Announces Sale-Leaseback Transaction Generating $102.25 Million in Non-Dilutive Gross ProceedsGlobeNewsWire • 09/29/21
MannKind Corporation to Participate at Lytham Partners Fall 2021 Investor ConferenceGlobeNewsWire • 09/28/21